Our first dedicated UK clinic brings together experience from our German radiotherapy network and local healthcare expertise to support responsible access to treatment.

Expanding access to care means bringing the right expertise closer to the people who need it. With the opening of our first dedicated UK low-dose radiotherapy (LDRT) clinic in Alderley Edge, Cheshire, near Manchester, we are taking another step in that direction.
The clinic is part of our wider initiative to expand access to LDRT across Europe. It combines the UK team’s specialist expertise and understanding of local patient needs with extensive experience from our German radiotherapy network.
One of the strengths of a European healthcare group is the opportunity to share experience across countries while recognising the needs of each local healthcare system. In Alderley Edge, that means bringing established LDRT expertise from Germany together with the UK team’s experience in healthcare delivery.
Our German radiotherapy network treats more than 20,000 LDRT patients annually. In Germany, LDRT is an established treatment option for selected musculoskeletal, inflammatory and proliferative conditions, supported by national clinical guidelines and reimbursement from statutory health insurers.
Sharing expertise is only part of the picture. The team developing the Alderley Edge clinic brought together clinical knowledge and healthcare delivery experience to shape a service that reflects local referral pathways, patient needs and clinical practice.
As we expand patient access to low-dose radiotherapy in new markets, we can demonstrate one of the strengths of working as a European group: bringing established expertise from one country to another and combining it with local healthcare delivery experience. The new Ergéa Low-Dose Radiotherapy clinic in Alderley Edge brings the world-leading low-dose radiotherapy expertise developed in Germany to patients in the UK.
David Rolfe, CEO, Ergéa Group
As we expand patient access to low-dose radiotherapy in new markets, we can demonstrate one of the strengths of working as a European group: bringing established expertise from one country to another and combining it with local healthcare delivery experience. The new Ergéa Low-Dose Radiotherapy clinic in Alderley Edge brings the world-leading low-dose radiotherapy expertise developed in Germany to patients in the UK.
Dr. Sandra Röddiger and Dr. Ralf Kurek, Co-Chairs of the Board of Directors at Ergéa Group
The Ergéa Low-Dose Radiotherapy clinic in Alderley Edge provides treatments for selected conditions such as osteoarthritis, plantar fasciitis, Achilles and other tendinopathies, bursitis, tennis or golfer’s elbow, Dupuytren’s contracture and Ledderhose disease and keloid scarring. Patients are individually assessed to determine whether treatment is suitable for their condition and circumstances. The clinic operates separately from Ergéa UK’s hospital partnerships business.
More information about Ergéa Alderley Edge Low-Dose Radiotherapy clinic is available at https://ergeaclinics.co.uk




